Skip to content

Clinical trials

Expanded access Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Expanded access Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available7
Approved for marketing6
Available5
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Novartis Pharmaceuticals4
Genentech, Inc.2
AIO-Studien-gGmbH1
AVM Biotechnology Inc1
Aveni Foundation1
Eisai Inc.1
Merus B.V.1
Novartis1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms19
Pancreatic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Prostatic Neoplasms4
Ovarian Neoplasms3
Brain Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Neoplasms2
Sarcoma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.